Insights

  • Date

  • Content Type

  • Reset

Article

Bringing Novel Therapies to Market: 5 Strategies for Success

10.01.22
By Christian K. Schneider, MD

Advanced therapy medicinal products (ATMPs) were making headlines long before SARS-CoV-2, the virus that causes...
Read More

Article

Five Strategies for Success in Bringing Novel Therapies to Market

10.01.22
By Christian K Schneider

Advanced therapy medicinal products (ATMPs), as they’re called in the European Union and the UK, or...
Read More

Article

Designing Vaccines: The Role of Artificial Intelligence and Digital Health, Part 2

16.12.21
By Aleksandra Nevmerzhitskaya

In BPI’s October 2021 issue, part one of this review introduced the concepts of machine learning (ML)...
Read More

Article

Five marketing strategies for novel therapeutics

8.12.21
By Christian K Schneider

Long before the advent of Coronavirus, next-generation therapies were making headlines, but the successful development of...
Read More

Article

Marketing strategies for next-gen therapies

2.12.21
By Christian K Schneider

The successful development of COVID-19 vaccines, including mRNA vaccines, has shone a spotlight on next-generation therapies...
Read More

Article

Designing Vaccines: The Role of Artificial Intelligence and Digital Health, Part 1

9.11.21
By Aleksandra Nevmerzhitskaya

According to the founder and executive chairman of the World Economic Forum, Klaus Schwab
Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more